Autologous stem cell transplantation for multiple myeloma patients aged ≥ 75 treated with novel agents
Iuliana Vaxman(Tel Aviv University), Morie A. Gertz(Medical University of South Carolina), Francis K. Buadi, Nelson Leung(WinnMed), Shaji Kumar(Mayo Clinic), Prashant Kapoor, Tamar Berger(Tel Aviv University), Rahma Warsame, Wilson I. Gonsalves(Mayo Clinic in Arizona), Alissa Visram(McMaster University), Taxiarchis Kourelis(Mayo Clinic in Arizona), Martha Q. Lacy(Mayo Clinic), Eli Muchtar(Mayo Clinic), William J. Hogan(Mayo Clinic), Angela Dispenzieri(Mayo Clinic), Suzanne R. Hayman, David Dingli
Cited by 21
Related Papers
International uniform response criteria for multiple myeloma
|Leukemia|2006|2.6k
Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group
|Journal of Clinical Oncology|2015|2.2k
Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis
|Circulation|2016|2k
CRITERIA FOR EVALUATING DISEASE RESPONSE AND PROGRESSION IN PATIENTS WITH MULTIPLE MYELOMA TREATED BY HIGH‐DOSE THERAPY AND HAEMOPOIETIC STEM CELL TRANSPLANTATION
|British Journal of Haematology|1998|1.5k